Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma

European Journal of Surgical Oncology

Volumn 33, Issue 8, 2007, Pages 1025-1029

  Mobius C ^a   Demuth, C ^a   Aigner, T ^a   Wiedmann, M ^a   Wittekind, C ^a   Mossner J ^a   Hauss, J ^a   Witzigmann, H ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Angiogenesis, VEGF; Extrahepatic cholangiocarcinoma; Survival

Indexed keywords

CD34 ANTIGEN; PARAFFIN; VASCULOTROPIN A;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; CALCULATION; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TUMOR CELL; TUMOR VASCULARIZATION;

ADULT; AGED; ANTIGENS, CD34; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; CHOLANGIOCARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34548615691     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.02.020     Document Type: Article

References (32)

1. de Groen P.C., Gores G.J., LaRusso N.F., Gunderson L.L., and Nagorney D.M. Biliary tract cancers. N Engl J Med 341 (1999) 1368-1378
2. Welzel T.M. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 98 (2006) 873-875
3. Schurr R., Stolzel U., Schuppan D., Schwertner C., Steinberg J., and Scherubl H. Increased incidence of hepatocellular and intrahepatic cholangiocellular carcinoma in northeast Germany. Dtsch Med Wochenschr 131 (2006) 1649-1655
4. West J., Wood H., Logan R.F.A., Quinn M., and Aithal G.P. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer 94 (2006) 1751-1758
5. Khan S.A., Thomas H.C., Davidson B.R., and Taylor-Robinson S.D. Cholangiocarcinoma. Lancet 366 (2005) 1303-1314
6. Okuda K., Nakanuma Y., and Miyazaki M. Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol 17 (2002) 1049-1055
7. Lazaridis K.N., and Gores G.J. Cholangiocarcinoma. Gastroenterology 128 (2005) 1655-1667
8. Malka D., Boige V., Dromain C., Debaere T., Pocard M., and Ducreux M. Biliary tract neoplasms: update 2003. Curr Opinion Oncol 16 (2004) 364-371
9. Khan S.A., Davidson B.R., and Goldin R. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. GUT 51 Suppl. (2002) 1-19
10. Singhal D., van Gulik T.M., and Gouma D.J. Palliative management of hilar cholangiocarcinoma. Surg Oncol 14 (2005) 59-74
11. Thongprasert S. The role of chemotherapy in cholangiocarcinoma. Ann Oncol 16 Suppl. 2 (2005) 93-96
12. Marme D. The impact of anti-angiogenic agents on cancer therapy. J Cancer Res Clin Oncol 11 (2003) 607-620
13. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
14. Stein H.J., and Mobius C. Angiogenesis and neoplastic transformation of Barrett's epithelium. Br J Surg 91 (2004) 941-942
15. Ogawa Y., Chung Y.S., Nakata B., et al. Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen. Br J Cancer 71 (1995) 1297-1301
16. Macchiarini P., Fontanini G., Hardin M.J., et al. Relation of neovasculature to metastasis of non-small-cell lung cancer. Lancet 340 (1992) 145-146
17. Mobius C., Stein H.J., Becker I., et al. Vascular endothelial growth factor expression and neovascularization in Barrett's carcinoma. World J Surg 28 (2004) 675-679
18. Siemann D.W., Bibby M.C., Dark G.G., et al. Differentiation and definition of vascular-targeted therapie. Clin Can Res 416 (2005) 416-420
19. Tang D., Nagano H., Yamamoto H., et al. Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance. Oncol Rep 15 (2006) 525-532
20. Kawahara N., Ono M., Taguchi K., et al. Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma. Hepatology 28 (1998) 1512-1517
21. Ogasawara S., Yano H., Higaki K., et al. Expression of angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in human biliary tract carcinoma cell lines. Hepatol Res 20 (2001) 97-113
22. In: Sobin L.H., and Wittekind C. (Eds). UICC: TNM classification of malignant tumors. 6th ed. (2002), Wiley-Liss, New York 74-85
23. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324 (1991) 1-8
24. Mobius C, Freire J, Becker J, et al. VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus. World J Surg, in press.
25. Neuhaus P., Jonas S., Settmacher U., et al. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg 388 (2003) 194-200
26. Jarnagin W.R., and Shoup M. Surgical management of cholangiocarcinoma. Semin Liver Dis 24 (2004) 189-199
27. Witzigmann H., Berr F., Ringel U., et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to R1/R2 resection. Ann Surg 244 (2006) 230-239
28. Okuda K., Nakanuma Y., and Miyazaka M. Cholangiocarcinoma: recent progress. Part 2: molecular pathology and treatment. J Gastroenterol Hepatol 17 (2002) 1056-1063
29. Dameron K.M., Volpert O.V., Tainsky M.A., and Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265 (1994) 483-489
30. Hida Y., Morita T., Fujita M., et al. Vascular endothelial growth factor expression is an independent negative predictor in extrahepatic biliary tract carcinomas. Anticancer Res 19 (1999) 2257-2260
31. Benckert C., Jonas S., Cramer T., et al. Transforming growth factor β1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells. Cancer Res 63 (2003) 1083-1092
32. Ortner M.E., Caca K., Berr F., et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 25 (2003) 1355-1363